Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
SBI Healthcare Opp Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.13.45292800000485.7160
Domestic EquitiesMax Healthcare Institute Ltd.6.68412200000241.3290
Domestic EquitiesDivi's Laboratories Ltd.5.9986375000216.5794
Domestic EquitiesCipla Ltd.4.79331200000173.0640
Domestic EquitiesLupin Ltd.4.7181840000170.3478
Domestic EquitiesMankind Pharma Ltd.3.7609560000135.7860
Domestic EquitiesKrishna Institute of Medical Sciences Ltd.3.72012100000134.3160
Domestic EquitiesJupiter Life Line Hospitals Ltd.3.5376800000127.7240
Domestic EquitiesAmi Organics Ltd.3.3801500000122.0400
Domestic EquitiesPolymedicure Ltd.3.3581540000121.2435
Domestic EquitiesFortis Healthcare Ltd.3.32691720000120.1162
Domestic EquitiesAether Industries Ltd.3.22231400000116.3400
Domestic EquitiesAbbott India Ltd.3.063136000110.5940
Domestic EquitiesLaurus Labs Ltd.3.05811800000110.4120
Domestic EquitiesAster DM Healthcare Ltd.2.94612200000106.3700
Domestic EquitiesAlkem Laboratories Ltd.2.704220000097.6340
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.682130000096.8385
Domestic EquitiesAurobindo Pharma Ltd.2.571480000092.8400
Domestic EquitiesRainbow Children's Medicare Ltd.2.484764000089.7088
Domestic EquitiesGland Pharma Ltd.2.401054438086.6871
Domestic EquitiesBiocon Ltd.1.8928200000068.3400
Domestic EquitiesSuven Pharmaceuticals Ltd.1.723454060462.2235
Domestic EquitiesVijaya Diagnostic Centre Ltd.1.673860000060.4320
Domestic EquitiesConcord Biotech Ltd.1.287527659946.4852
Domestic EquitiesPfizer Ltd.1.109110000040.0450
Domestic EquitiesAkums Drugs & Pharmaceuticals Ltd.1.091183253239.3954
Domestic EquitiesSanofi Consumer Healthcare India Ltd.1.00267500036.2006
Domestic EquitiesGufic Biosciences Ltd.0.9314100000033.6300
Total 92.5753 3342.4380
Cash & Cash Equivalents and Net AssetsTREPS3.1581 114.0247
Cash & Cash Equivalents and Net AssetsNet Receivable / Payable-0.1996 -7.2058
Total 2.9586 106.8189
Treasury Bills182 DAY T-BILL 05.06.250.08223000002.9661
Total 0.0822 2.9661
Overseas EquitiesLonza Group4.3840300000158.2828
Total 4.3840 158.2828
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.